Stay updated on Dapagliflozin in Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Respiratory Failure Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%
- Check19 days agoChange Detected- Page version updates to v3.1.0. - Several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating a narrowing of scope or rebranding rather than the addition of new topics.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check47 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new medical topics such as Drug Safety and Post-COVID Conditions. Notably, the previous mentions of specific locations and drugs have been removed, indicating a shift in focus or content structure.SummaryDifference14%
- Check54 days agoChange DetectedThe company name has changed from George Clinical Pty Ltd to Emerald Clinical Inc.SummaryDifference0.1%
Stay in the know with updates to Dapagliflozin in Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.